Top Clinical Nutrition Companies

Clinical Nutrition Market size was valued at USD 41.76 Billion in 2024 and is poised to grow from USD 45.06 Billion in 2025 to USD 82.78 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026–2033).

The clinical nutrition market is relatively fragmented, with a high level of competition. Few large players, like Glanbia Plc, Pfizer Inc., and Danone Nutricia, now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Abbott Laboratories (U.S.) ', 'Nestlé Health Science (Switzerland) ', 'Danone Nutricia (France) ', 'Fresenius Kabi (Germany) ', 'Baxter International (U.S.) ', 'B. Braun Melsungen AG (Germany) ', 'Mead Johnson Nutrition (Reckitt) (U.S.) ', 'GlaxoSmithKline (GSK) (U.K.) ', 'Pfizer (U.S.) ', 'Ajinomoto Co., Inc. (Japan) ', 'Koninklijke DSM N.V. (Netherlands) ', 'Lonza Group (Switzerland) ', 'Cambrooke Therapeutics (U.S.) ', 'Sichuan Kelun Pharmaceutical Co. Ltd. (China) ', 'Otsuka Pharmaceutical (Japan) ', 'Hormel Health Labs (U.S.) ', 'Perrigo Company (Ireland) ', 'Hero Group (Switzerland) ', 'Victus (U.S.) ', 'Entrocare Nutritional Solutions (U.K.)'

The increase in the elderly population is driving the expansion of the global clinical nutrition market. As humans age, they become less active, their metabolism slows, and their energy requirements drop, as their ability to absorb and utilize nutrients degrades. Consequently, their nutritional needs increase. These are the major factors driving the demand for clinical nutrition for better energy absorption and utilization which will propel the market growth during the analysis period.

Improved healthcare infrastructure and rising demand for better healthcare present lucrative growth possibilities for the clinical nutrition market in the emerging nations of Asia-Pacific and LAMEA. In addition, the increase in the incidence of various lifestyle and chronic diseases that lead to malnutrition and dietary problems, as well as the increase in the research required for the development of medical devices for clinical nutrition of a variety of diseases such as respiratory, renal, and cancer, have boosted the demand for the clinical nutrition market.

In 2021, North America accounts for the largest share of the market and is expected to register a CAGR of 5.5% during the projected period. Continuous clinical nutrition R&D is a key trend in the clinical nutrition sector in North America. In addition, for several chronic diseases, including coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. Diabetes prevalence has boosted the demand for medical nutrition therapy. In addition, the expanding demand for clinical nutrition in the pediatric sector is likely to present market participants with lucrative growth opportunities and drive the clinical nutrition market size during the analysis period.